Pendulum Therapeutics Inc
USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Pendulum ranks #23,176 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.
- #23,176
- of 49,997 US assignees by volume
- Top 40%
- by Innovation Score (38.6/100)
- 20.8
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R23176 · US Corporation #23,176 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 12 grants
- MID-PACK #23,176/49,997
- PHOTO-FINISH Parker Hannifin…
- CPC-NARROW A61P · 9 areas
- INNOV-THIN 38.6/100
- CLAIMS-DENSE 20.8 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Parker Hannifin Manufacturing France (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Pendulum’s 38.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Pendulum
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Pendulum Therapeutics · this assignee
Pendulum Therapeutics · this assignee
39 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Pendulum's Innovation Score is 38.6/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Pendulum?
Each dot is one of Pendulum’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pendulum’s own 20.8 claims/patent is ABOVE the 13.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Pendulum's grants concentrate
Pendulum Therapeutics Inc is a focused PatentsView assignee: 9 CPC subclasses with 91.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2023. By volume, Pendulum sits between Parker Hannifin Manufacturing France and Pernix Sleep, Inc..
Pendulum's three-year grant acceleration
Pendulum Therapeutics Inc shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Pendulum's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Parker Hannifin M…
Parker Hannifin Manufacturing France
12 patents
- Patent & Investme…
Patent & Investment LLC
12 patents
- Path Robotics
Path Robotics, Inc.
12 patents
- Paulson Manufactu…
Paulson Manufacturing Corporation
12 patents
- Penguin Magic
Penguin Magic, Inc.
12 patents
- Performance Indic…
Performance Indicator, LLC
12 patents
- Performance Plants
Performance Plants Inc.
12 patents
- Pernix Sleep
Pernix Sleep, Inc.
12 patents
- Pendulum Therapeu… ◀
Pendulum Therapeutics Inc
12 patents
What this shows Pendulum holds 12 patents at rank #23,197, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Pendulum
By rank, the assignees closest to #23,197 in granted patent volume.
- Parker Hannifin Manufacturing France #23,193 · 12 patents
- Patent & Investment LLC #23,194 · 12 patents
- Path Robotics, Inc. #23,195 · 12 patents
- Paulson Manufacturing Corporation #23,196 · 12 patents
- Penguin Magic, Inc. #23,198 · 12 patents
- Performance Indicator, LLC #23,199 · 12 patents
- Performance Plants Inc. #23,200 · 12 patents
- Pernix Sleep, Inc. #23,201 · 12 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Pendulum's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Pendulum's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 5 | 41.7% |
| 2022 | 3 | 25.0% |
| 2023 | 1 | 8.3% |
| 2024 | 1 | 8.3% |
| 2025partial year | 2 | 16.7% |
Which technologies does Pendulum Therapeutics Inc patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Pendulum Therapeutics Inc's patent record in context - here's where to go next.
- Pendulum Therapeutics Inc's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 91.7% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #23,176 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Pendulum Therapeutics Inc against Parker Hannifin Manufacturing France, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 38.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.